Filing Flows › Veracyte (VCYT) › Operating margin
Veracyte (VCYT) operating margin by quarter
Veracyte's operating margin was 10.9% in Q3 2026 (third quarter 2026), -4.4 pts from Q2 2026. Over the last 6 quarters it ranged from 2.5% (Q1 2025) to 26.4% (Q4 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 10.9% | -4.4 pts | -6.5 pts |
| Q2 2026 | 15.3% | -1.0 pts | — |
| Q1 2026 | 16.3% | -10.2 pts | +13.7 pts |
| Q4 2025 | 26.4% | +9.0 pts | — |
| Q3 2025 | 17.4% | +14.9 pts | — |
| Q1 2025 | 2.5% | — | — |
Q3 2026 at a glance
Veracyte, Q3 2026: revenue $152M (+15% year over year), operating margin 10.9%, net earnings $31.5M, operating cash flow $40.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Veracyte's operating margin?
Veracyte's operating margin was 10.9% in Q3 2026 (third quarter 2026), -4.4 pts from Q2 2026.
How has Veracyte's operating margin changed?
Over the last 6 quarters it ranged from 2.5% (Q1 2025) to 26.4% (Q4 2025).